Venatorx Pharmaceuticals, Inc. Email Format
Pharmaceutical ManufacturingPennsylvania, United States11-50 Employees
Venatorx Pharmaceuticals, Inc. is a private drug development company based in Malvern, Pennsylvania, focused on discovering and advancing novel anti-infectives to treat multi-drug-resistant bacteria and hard-to-treat viral infections. The organization aims to provide new therapeutic options for infections where current treatments are limited or ineffective. Operating within the pharmaceutical manufacturing sector, it pursues early-stage discovery and development of candidate medicines. With a small, specialized team, Venatorx emphasizes targeted research and strategic collaborations to progress its programs. A notable recent development is an exclusive licensing agreement with Basilea Pharmaceutica Ltd announced in August 2025, reflecting the company’s strategy of partnering to expand access to its anti-infective portfolio. This approach aligns with Venatorx’s overall focus on advancing treatments for resistant infections through collaborations with other industry players.